Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-44447-1.pdf
Reference27 articles.
1. Bosetti, C., Turati, F. & La Vecchia, C. Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 28, 753–770, https://doi.org/10.1016/j.bpg.2014.08.007 (2014).
2. Golabi, P. et al. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore) 96, e5904, https://doi.org/10.1097/MD.0000000000005904 (2017).
3. Zhu, R. X., Seto, W. K., Lai, C. L. & Yuen, M. F. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver 10, 332–339, https://doi.org/10.5009/gnl15257 (2016).
4. Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I. & Taylor-Robinson, S. D. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14, 4300–4308 (2008).
5. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348, 1625–1638, https://doi.org/10.1056/NEJMoa021423 (2003).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes;Gastroenterology;2024-04
2. The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-01
3. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01
4. Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis;World Journal of Clinical Cases;2023-02-16
5. Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease;Hepatoma Research;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3